Literature DB >> 2118724

Cyclooxygenase inhibition enhances rat interleukin 1 beta-induced growth of rat mesangial cells in culture.

R A Stahl1, F Thaiss, U Haberstroh, S Kahf, A Shaw, W Schoeppe.   

Abstract

The cytokine interleukin 1 (IL-1) has growth-promoting activities on mesangial cells (MC) and enhances MC prostanoid formation. A possible role of endogenous cyclooxygenase products on IL-1-mediated growth of MC is, however, unknown. Therefore we evaluated the effect of cyclooxygenase inhibition on growth of mesangial cells in culture, which were exposed to DNA recombinant rat interleukin 1 beta (rIL-1 beta). rIL-1 beta increased [3H]thymidine uptake in MC by approximately 70% after 48 h. This growth-promoting activity of the cytokine was observed at 1 ng/ml and was not further enhanced by the increase of the IL-1 beta concentration less than or equal to 100-fold. IL-1 beta, however, dose dependently stimulated prostaglandin E2 (PGE2) formation by MC. When prostaglandin synthesis was inhibited by indomethacin (Indo, 1 microgram/ml), rIL-1 beta (10 ng/ml)-induced cell proliferation was sevenfold greater compared with rIL-1 beta alone. In the presence of Indo (1 microgram/ml), rIL-1 beta (1, 10, 50, and 100 ng/ml) dose dependently stimulated MC proliferation. The addition of exogenous PGE2 (10(-7) and 10(-8) M) to Indo-treated MC blocked the mitogenic response of IL-1 beta. We conclude that endogenous PGE2 formation, which is stimulated by IL-1 beta, antagonizes the growth-promoting activity of the cytokine. PGE2 may thus exert antiproliferative effects in glomerular diseases, whereas IL-1 might mediate cell growth.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118724     DOI: 10.1152/ajprenal.1990.259.3.F419

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

Review 1.  New molecular insights in diabetic nephropathy.

Authors:  Ionel Alexandru Checheriţă; Gina Manda; Mihai Eugen Hinescu; Ileana Peride; Andrei Niculae; Ştefana Bîlha; Angelica Grămăticu; Luminiţa Voroneanu; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2016-01-12       Impact factor: 2.370

2.  Kinase-dependent, retinoic acid receptor-independent up-regulation of cyclooxygenase-2 by all-trans retinoic acid in human mesangial cells.

Authors:  M Alique; V Moreno; M Kitamura; Q Xu; F J Lucio-Cazana
Journal:  Br J Pharmacol       Date:  2006-08-07       Impact factor: 8.739

Review 3.  Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.

Authors:  Raimund Pichler; Maryam Afkarian; Brad P Dieter; Katherine R Tuttle
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-24

4.  CCAAT/enhancer-binding protein-delta is induced in mesangial area during the early stages of anti-Thy1.1 glomerulonephritis and regulates cell proliferation and inflammatory gene expression in cultured rat mesangial cells.

Authors:  Ken-ichi Miyoshi; Takafumi Okura; Tomikazu Fukuoka; Jitsuo Higaki
Journal:  Clin Exp Nephrol       Date:  2007-03-28       Impact factor: 2.801

5.  Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: modulation and/or suppression by inflammatory cytokines.

Authors:  J Floege; N Topley; J Hoppe; T B Barrett; K Resch
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

6.  Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.

Authors:  J R Vane; J A Mitchell; I Appleton; A Tomlinson; D Bishop-Bailey; J Croxtall; D A Willoughby
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

7.  Attenuation of immune complex nephritis in NZB/WF1 mice by a prostacyclin analogue.

Authors:  Y Utsunomiya; M Ogura; T Kawamura; T Mitarai; N Maruyama; O Sakai
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

8.  Interleukin 1 beta-induced calcium signaling via TRPA1 channels promotes mitogen-activated protein kinase-dependent mesangial cell proliferation.

Authors:  Hitesh Soni; Ravi Kumar; Praghalathan Kanthakumar; Adebowale Adebiyi
Journal:  FASEB J       Date:  2021-07       Impact factor: 5.834

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.